Výsledky vyhledávání - Hoog, Jeremy
- Zobrazuji výsledky 1 - 20 z 37
- Přejít na další stránku
-
1
Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer Autor Rajput, Sandeep, Khera, Nimmish, Guo, Zhanfang, Hoog, Jeremy, Li, Shunqiang, Ma, Cynthia X.
Vydáno 2016Text -
2
Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER(+) breast cancer Autor Shee, Kevin, Jiang, Amanda, Varn, Frederick S., Liu, Stephanie, Traphagen, Nicole A., Owens, Philip, Ma, Cynthia X., Hoog, Jeremy, Cheng, Chao, Golub, Todd R., Straussman, Ravid, Miller, Todd W.
Vydáno 2019Text -
3
Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance) Autor Anurag, Meenakshi, Zhu, Mayanne, Huang, Chen, Vasaikar, Suhas, Wang, Junkai, Hoog, Jeremy, Burugu, Samantha, Gao, Dongxia, Suman, Vera, Zhang, Xiang H, Zhang, Bing, Nielsen, Torsten, Ellis, Matthew J
Vydáno 2019Text -
4
Vav1/2/3-null Mice Define an Essential Role for Vav Family Proteins in Lymphocyte Development and Activation but a Differential Requirement in MAPK Signaling in T and B Cells Autor Fujikawa, Keiko, Miletic, Ana V., Alt, Frederick W., Faccio, Roberta, Brown, Tracie, Hoog, Jeremy, Fredericks, Jessica, Nishi, Shinzo, Mildiner, Shirly, Moores, Sheri L., Brugge, Joan, Rosen, Fred S., Swat, Wojciech
Vydáno 2003Text -
5
A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor Positive Metastatic Breast Cancer Autor Ma, Cynthia X., Sanchez, Cesar, Gao, Feng, Crowder, Robert, Naughton, Michael, Pluard, Timothy, Creekmore, Allison, Guo, Zhanfang, Hoog, Jeremy, Lockhart, A. Craig, Doyle, Laurence, Erlichman, Charles, Ellis, Matthew J.
Vydáno 2016Text -
6
Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: feasibility of an antibody-based companion diagnostic agent Autor Marquez-Nostra, Bernadette V., Lee, Supum, Laforest, Richard, Vitale, Laura, Nie, Xingyu, Hyrc, Krzysztof, Keler, Tibor, Hawthorne, Thomas, Hoog, Jeremy, Li, Shunqiang, Dehdashti, Farrokh, Ma, Cynthia X., Lapi, Suzanne E.
Vydáno 2017Text -
7
Epigenetic activation of the prostaglandin receptor EP4 promotes resistance to endocrine therapy for breast cancer Autor Hiken, Jeffrey F., McDonald, James I., Decker, Keith F., Sanchez, Cesar, Hoog, Jeremy, VanderKraats, Nathan D., Jung, Kyle L., Akinhanmi, Margaret, Rois, Lisa E., Ellis, Matthew J., Edwards, John R.
Vydáno 2016Text -
8
Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models Autor Ma, Cynthia X., Cai, Shirong, Li, Shunqiang, Ryan, Christine E., Guo, Zhanfang, Schaiff, W. Timothy, Lin, Li, Hoog, Jeremy, Goiffon, Reece J., Prat, Aleix, Aft, Rebecca L., Ellis, Matthew J., Piwnica-Worms, Helen
Vydáno 2012Text -
9
Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models Autor Ma, Cynthia X., Cai, Shirong, Li, Shunqiang, Ryan, Christine E., Guo, Zhanfang, Schaiff, W. Timothy, Lin, Li, Hoog, Jeremy, Goiffon, Reece J., Prat, Aleix, Aft, Rebecca L., Ellis, Matthew J., Piwnica-Worms, Helen
Vydáno 2012Text -
10
Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer Autor Goncalves, Rodrigo, DeSchryver, Katherine, Ma, Cynthia, Tao, Yu, Hoog, Jeremy, Cheang, Maggie, Crouch, Erika, Dahiya, Neha, Sanati, Souzan, Barnes, Michael, Sarian, Luis Otávio Zanatta, Olson, John, Allred, Donald Craig, Ellis, Matthew J.
Vydáno 2017Text -
11
Cancer-associated exportin-6 upregulation inhibits the transcriptionally repressive and anticancer effects of nuclear profilin-1 Autor Zhu, Cuige, Kim, Sun-Joong, Mooradian, Arshag, Wang, Faliang, Li, Ziqian, Holohan, Sean, Collins, Patrick L., Wang, Keren, Guo, Zhanfang, Hoog, Jeremy, Ma, Cynthia X., Oltz, Eugene M., Held, Jason M., Shao, Jieya
Vydáno 2021Text -
12
Proteomic Resistance Biomarkers for PI3K Inhibitor in Triple Negative Breast Cancer Patient-Derived Xenograft Models Autor Guo, Zhanfang, Primeau, Tina, Luo, Jingqin, Zhang, Cynthia, Sun, Hua, Hoog, Jeremy, Gao, Feng, Huang, Shixia, Edwards, Dean P., Davies, Sherri R., Aft, Rebecca, Ding, Li, Ellis, Matthew J., Li, Shunqiang, Ma, Cynthia X.
Vydáno 2020Text -
13
Relationship Between Plasma Estradiol Levels and Estrogen-Responsive Gene Expression in Estrogen Receptor–Positive Breast Cancer in Postmenopausal Women Autor Dunbier, Anita K., Anderson, Helen, Ghazoui, Zara, Folkerd, Elizabeth J., A'Hern, Roger, Crowder, Robert J., Hoog, Jeremy, Smith, Ian E., Osin, Peter, Nerurkar, Ashutosh, Parker, Joel S., Perou, Charles M., Ellis, Matthew J., Dowsett, Mitch
Vydáno 2010Text -
14
An mRNA Gene Expression–Based Signature to Identify FGFR1-Amplified Estrogen Receptor–Positive Breast Tumors Autor Luo, Jingqin, Liu, Shuzhen, Leung, Samuel, Gru, Alejandro A., Tao, Yu, Hoog, Jeremy, Ho, Julie, Davies, Sherri R., Allred, D. Craig, Salavaggione, Andrea L., Snider, Jacqueline, Mardis, Elaine R., Nielsen, Torsten O., Ellis, Matthew J.
Vydáno 2017Text -
15
Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib Autor Bagegni, Nusayba, Thomas, Shana, Liu, Ning, Luo, Jingqin, Hoog, Jeremy, Northfelt, Donald W., Goetz, Matthew P., Forero, Andres, Bergqvist, Mattias, Karen, Jakob, Neumüller, Magnus, Suh, Edward M., Guo, Zhanfang, Vij, Kiran, Sanati, Souzan, Ellis, Matthew, Ma, Cynthia X.
Vydáno 2017Text -
16
Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer Autor Ellis, Matthew J, Lin, Li, Crowder, Robert, Tao, Yu, Hoog, Jeremy, Snider, Jacqueline, Davies, Sherri, DeSchryver, Katherine, Evans, Dean B, Steinseifer, Jutta, Bandaru, Raj, Liu, WeiHua, Gardner, Humphrey, Semiglazov, Vladimir, Watson, Mark, Hunt, Kelly, Olson, John, Baselga, José
Vydáno 2010Text -
17
PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor positive breast cancer Autor Crowder, Robert J., Phommaly, Chanpheng, Tao, Yu, Hoog, Jeremy, Luo, Jingqin, Perou, Charles M., Parker, Joel S., Miller, Melinda A., Huntsman, David G., Lin, Li, Snider, Jacqueline, Davies, Sherri R., Olson, John A., Watson, Mark A., Saporita, Anthony, Weber, Jason D., Ellis, Matthew J.
Vydáno 2009Text -
18
ESR1 gene amplification in breast cancer: a common phenomenon? Autor Brown, Lindsay A, Hoog, Jeremy, Chin, Suet-Feung, Tao, Yu, Zayed, Abd Alnaser, Chin, Koei, Teschendorff, Andrew E, Quackenbush, John F, Marioni, John C, Leung, Samuel, Perou, Charles M, Neilsen, Torsten O, Ellis, Matthew, Gray, Joe W, Bernard, Philip S, Huntsman, David G, Caldas, Carlos
Vydáno 2008Text -
19
A phase 1 trial of BKM120 (Buparlisib) in combination with fulvestrant in postmenopausal women with estrogen receptor positive metastatic breast cancer Autor Ma, Cynthia X., Luo, Jingqin, Naughton, Michael, Ademuyiwa, Foluso, Suresh, Rama, Griffith, Malachi, Griffith, Obi L., Skidmore, Zachary L., Spies, Nicholas C., Ramu, Avinash, Trani, Lee, Pluard, Timothy, Nagaraj, Gayathri, Thomas, Shana, Guo, Zhanfang, Hoog, Jeremy, Han, Jing, Mardis, Elaine, Lockhart, Craig, Ellis, Matthew J.
Vydáno 2015Text -
20
Loss of MutL disrupts Chk2-dependent cell cycle control through CDK4/6 to promote intrinsic endocrine therapy resistance in primary breast cancer Autor Haricharan, Svasti, Punturi, Nindo, Singh, Purba, Holloway, Kimberly R., Anurag, Meenakshi, Schmelz, Jacob, Schmidt, Cheryl, Lei, Jonathan T., Suman, Vera, Hunt, Kelly, Olson, John A., Hoog, Jeremy, Li, Shunqiang, Huang, Shixia, Edwards, Dean P., Kavuri, Shyam M., Bainbridge, Matthew N., Ma, Cynthia X., Ellis, Matthew J.
Vydáno 2017Text